Ampio Pharmaceuticals Inc.
AMPE
AMPE was delisted on the 12th of April, 2024.
121 hedge funds and large institutions have $72.6M invested in Ampio Pharmaceuticals Inc. in 2021 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 31 increasing their positions, 28 reducing their positions, and 13 closing their positions.
728% more call options, than puts
Call options by funds: $1.94M | Put options by funds: $234K
11% more repeat investments, than reductions
Existing positions increased: 31 | Existing positions reduced: 28
3% less capital invested
Capital invested by funds: $75.2M → $72.6M (-$2.58M)
5% less funds holding
Funds holding: 128 → 121 (-7)
46% less first-time investments, than exits
New positions opened: 7 | Existing positions closed: 13
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
State Street
Boston,
Massachusetts
|
+$978K |
| 2 |
D.E. Shaw & Co
New York
|
+$567K |
| 3 |
BJL
Brighton Jones LLC
Seattle,
Washington
|
+$307K |
| 4 |
BlackRock
New York
|
+$225K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$204K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
First Trust Advisors
Wheaton,
Illinois
|
-$763K |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$524K |
| 3 |
Jane Street
New York
|
-$283K |
| 4 |
SFS
Strategic Financial Services
Utica,
New York
|
-$278K |
| 5 |
California State Teachers Retirement System (CalSTRS)
West Sacramento,
California
|
-$239K |
AMPE Hedge Fund Activity: Q3 2021 in Review
121 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in Ampio Pharmaceuticals Inc. (AMPE) for Q3 2021, worth a combined $72.6M — down 3.4% from $75.2M a quarter earlier.
Sellers outnumbered buyers: 13 funds closed out of AMPE and 7 opened new positions — a net loss of 6 holders — while 28 trimmed existing stakes and 31 added.
The largest buyer was State Street, adding an estimated $978K. The largest seller was First Trust Advisors, exiting entirely with an estimated $763K sold.
- 121 institutional investors held Ampio Pharmaceuticals Inc. (AMPE) as of Q3 2021, down from 128 in Q2 2021.
- Funds reported $72.6M of Ampio Pharmaceuticals Inc. stock for Q3 2021, down 3.4% quarter-over-quarter.
- 7 funds opened new Ampio Pharmaceuticals Inc. positions in Q3 2021 and 13 closed out, a net change of -6 holders.
- The largest Ampio Pharmaceuticals Inc. buyer in Q3 2021 was State Street, an estimated $978K added.
- The largest Ampio Pharmaceuticals Inc. seller in Q3 2021 was First Trust Advisors, an estimated $763K sold.
Based on aggregated 13F filings for Q3 2021.